Flavonoids Regulate Redox-Responsive Transcription Factors in Glioblastoma and Microglia

• Published in: Cells (Basel, Switzerland) Switzerland), 2023-12, Vol.12 (24), p.2821
• Main Authors: Joma, Natali, Zhang, Issan, Righetto, Germanna L, McKay, Laura, Gran, Evan Rizzel, Kakkar, Ashok, Maysinger, Dusica
• Format: Article
• Language: English
• Subjects: Angiogenesis; Anti-inflammatory agents; Bioflavonoids; Brain cancer; Care and treatment; Cell culture; Flavones; Flavonoids; Flavonoids - pharmacology; Glioblastoma; Glioblastoma - drug therapy; Glioblastoma multiforme; Health aspects; High mobility group proteins; Humans; Hypoxia; Inflammation; Kelch-Like ECH-Associated Protein 1 - metabolism; Microglia; Microglia - metabolism; Molecular Docking Simulation; Molecular modelling; natural polyphenols; NF-E2-Related Factor 2 - metabolism; Oxidation-Reduction; Oxidation-reduction reaction; Oxidative stress; Polyphenols; Proteins; Quercetin; Quercetin - pharmacology; Reactive oxygen species; Therapeutic targets; Transcription factors; Transformed cells; Tumor Microenvironment; Tumorigenesis
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells12242821

The tumor microenvironment (TME) has emerged as a valuable therapeutic target in glioblastoma (GBM), as it promotes tumorigenesis via an increased production of reactive oxygen species (ROS). Immune cells such as microglia accumulate near the tumor and its hypoxic core, fostering tumor proliferation and angiogenesis. In this study, we explored the therapeutic potential of natural polyphenols with antioxidant and anti-inflammatory properties. Notably, flavonoids, including fisetin and quercetin, can protect non-cancerous cells while eliminating transformed cells (2D cultures and 3D tumoroids). We tested the hypothesis that fisetin and quercetin are modulators of redox-responsive transcription factors, for which subcellular location plays a critical role. To investigate the sites of interaction between natural compounds and stress-responsive transcription factors, we combined molecular docking with experimental methods employing proximity ligation assays. Our findings reveal that fisetin decreased cytosolic acetylated high mobility group box 1 (acHMGB1) and increased transcription factor EB (TFEB) abundance in microglia but not in GBM. Moreover, our results suggest that the most powerful modulator of the Nrf2-KEAP1 complex is fisetin. This finding is in line with molecular modeling and calculated binding properties between fisetin and Nrf2-KEAP1, which indicated more sites of interactions and stronger binding affinities than quercetin.